Białopiotrowicz et al. [23] reported PHGDH and PSAT1 to be upregulated in Burkitt lymphoma (BL) via a MYC/ATF4-dependent mechanism, with NCT-503 treatment leading to the decreased proliferation and clonogenicity of BL cells in vitro. Here, MYC is linked to Burkitt lymphoma.